CSIMarket
 


Integra Lifesciences Holdings Corp  (IART)
Other Ticker:  
 

Integra Lifesciences Holdings's Working Capital Ratio

IART's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth


Integra Lifesciences Holdings's Current Assets grew by 3 % in the IV Quarter 2023 sequentially, while Current Liabilities decreased, this led to improvement in Integra Lifesciences Holdings's Working Capital Ratio to 3.74, above Integra Lifesciences Holdings Corp average Working Capital Ratio.

Within Medical Equipment & Supplies industry 23 other companies have achieved higher Working Capital Ratio than Integra Lifesciences Holdings in forth quarter 2023. While Working Capital Ratio total ranking has improved so far during the IV Quarter 2023 to 431, from total ranking in the third quarter 2023 at 1540.

Explain Working Capital Ratio
How much in Current Assets IART´s has?
What is the value of IART´s Current Liabilities?


IART Working Capital Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Current Liabilities Change -11.76 % 16.84 % 27.71 % -10.62 % -5.62 %
Y / Y Current Assets Change -8.91 % -14.14 % -7.57 % -3.43 % 0.67 %
Working Capital Ratio MRQ 3.74 2.89 2.78 3.65 3.62
IART's Total Ranking # 431 # 1540 # 605 # 1333 # 1170
Seq. Current Liabilities Change -20.4 % -5.77 % 33.72 % -12.03 % 5.4 %
Seq. Current Assets Change 3 % -2.29 % 2.12 % -11.37 % -2.92 %



Working Capital Ratio forth quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 24
Healthcare Sector # 121
Overall Market # 431


Working Capital Ratio Statistics
High Average Low
4.62 3.62 2.36
(Mar 31 2014)   (Dec 31 2017)




Financial Statements
Integra Lifesciences Holdings's Current Liabilities $ 283 Millions Visit IART's Balance sheet
Integra Lifesciences Holdings's Current Assets $ 1,058 Millions Visit IART's Balance sheet
Source of IART's Sales Visit IART's Sales by Geography


Cumulative Integra Lifesciences Holdings's Working Capital Ratio

IART's Working Capital Ratio for the trailling 12 Months

IART Working Capital Ratio

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Current Liabilities TTM Growth -11.76 % 16.84 % 27.71 % -10.62 % -5.62 %
Y / Y Current Assets TTM Growth -8.91 % -14.14 % -7.57 % -3.43 % 0.67 %
Working Capital Ratio TTM 3.21 3.19 3.45 3.76 3.69
Total Ranking TTM # 282 # 3889 # 4026 # 3896 # 377
Seq. Current Liabilities TTM Growth -20.4 % -5.77 % 33.72 % -12.03 % 5.4 %
Seq. Current Assets TTM Growth 3 % -2.29 % 2.12 % -11.37 % -2.92 %


On the trailing twelve months basis Current Liabilities decreased faster than Integra Lifesciences Holdings's average Current Assets, this led to increase in in Integra Lifesciences Holdings's Working Capital Ratio to 3.21, Working Capital Ratio remained below IART average.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 23 other companies have achieved higher Working Capital Ratio than Integra Lifesciences Holdings. While Working Capital Ratio overall ranking has improved so far to 282, from total ranking during the twelve months ending third quarter 2023 at 3889.

Explain Working Capital Ratio
How much in Current Assets IART´s has?
What is the value of IART´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 24
Healthcare Sector # 114
Within the Market # 282


trailing twelve months Working Capital Ratio Statistics
High Average Low
4.44 3.47 2.78
(Sep. 30, 2014)   (Dec 31 2019)




Companies with similar Working Capital Ratio in the quarter ending Dec 31 2023, within Medical Equipment & Supplies Industry Working Capital RatioDec 31 2023 MRQ Current AssetsDec 31 2023 MRQ Current Liabilities
Orasure Technologies Inc  9.77 $ 386.459  Millions$ 39.536  Millions
Si bone inc   9.59 $ 211.394  Millions$ 22.040  Millions
Fonar Corporation  9.35 $ 132.542  Millions$ 14.179  Millions
Silk Road Medical Inc   7.95 $ 240.835  Millions$ 30.283  Millions
Procept Biorobotics Corporation  7.63 $ 350.567  Millions$ 45.927  Millions
Inspire Medical Systems inc   7.60 $ 593.739  Millions$ 78.105  Millions
Inspiremd Inc   7.34 $ 44.159  Millions$ 6.020  Millions
Orthopediatrics Corp  7.19 $ 226.496  Millions$ 31.517  Millions
Profound Medical Corp   6.58 $ 41.896  Millions$ 6.366  Millions
Lemaitre Vascular Inc   6.51 $ 194.598  Millions$ 29.879  Millions
Pulmonx Corporation  6.50 $ 150.422  Millions$ 23.157  Millions
The Beauty Health Company  6.07 $ 698.252  Millions$ 115.008  Millions
Penumbra Inc   6.06 $ 915.402  Millions$ 151.144  Millions
Zynex inc   6.01 $ 87.855  Millions$ 14.607  Millions
Electromed Inc   5.97 $ 39.265  Millions$ 6.573  Millions
Merit Medical Systems Inc  5.79 $ 1,108.470  Millions$ 191.477  Millions
Tandem Diabetes Care Inc   5.57 $ 747.989  Millions$ 134.204  Millions
Glaukos Corp  5.34 $ 395.461  Millions$ 74.014  Millions
Anika Therapeutics Inc   5.26 $ 163.309  Millions$ 31.059  Millions
Monogram Orthopaedics inc   5.19 $ 14.618  Millions$ 2.818  Millions
Nephros Inc   5.04 $ 8.405  Millions$ 1.667  Millions
Neuronetics inc   4.95 $ 93.793  Millions$ 18.967  Millions
Globus Medical Inc   4.88 $ 1,915.374  Millions$ 392.347  Millions
Clearpoint Neuro Inc   4.87 $ 36.172  Millions$ 7.430  Millions
Artivion Inc   4.85 $ 280.668  Millions$ 57.862  Millions
Intuitive Surgical Inc   4.76 $ 7,888.000  Millions$ 1,658.700  Millions
Koru Medical Systems Inc  4.55 $ 20.256  Millions$ 4.454  Millions
Bone Biologics Corporation  4.50 $ 3.738  Millions$ 0.831  Millions
Aethlon Medical Inc   3.93 $ 8.249  Millions$ 2.101  Millions
Tactile Systems Technology Inc   3.80 $ 145.294  Millions$ 38.250  Millions

Date modified: 2024-02-29T18:47:19+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com